Delivery Order SPE2DB22D1017-SPE2DB25FG8WF
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,567.90 on August 6, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,078.36. This firm fixed-price delivery order, which is not set aside for any specific business category, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is identified as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $69,230.76 on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 17, 2025, and represents a routine pharmaceutical procurement within the federal medical supply system. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) at a ceiling value of $3,324.60. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is set for ultimate completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,239.56 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order represents a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,823.85 on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count). This competitively awarded, firm fixed-price delivery order is expected to be completed by August 13, 2025, with fulfillment occurring at the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible vendors. This delivery order is...
- The Defense Logistics Agency awarded a $4,996.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets (60-count packages). This contract, which is not set-aside and competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania—which is also the place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,417.63 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded delivery order, utilizing firm fixed pricing with no set-aside designation, represents pharmaceutical procurement under AmerisourceBergen's broader supply agreement with the federal government. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a $1,913.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on August 14, 2025, with completion scheduled for August 15, 2025. This non-set-aside competitive award represents a pharmaceutical delivery under the agency's medical supply procurement operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal healthcare systems and...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8WFDelivery Order
The Defense Logistics Agency awarded a $6,130.28 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The contract performs at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains an extensive portfolio of federal contracts covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 8/4/25 |